Use of compounds that are combinations of selective antagonists of dopamine D2 Receptor Antagonists and agonists Selective 5-ht2a receptor, and Pharmaceutical Preparations Containing these compounds

摘要

Use of combinations of compounds which are Selective antagonists of dopamine D2 receptor and 5-ht1a receptor agonists, in particular (R) - (-) - 2 - [5 - (4-fluorophenyl) - 3 - piridilmetilaminometil chromane] - or Salt acceptable to use the same Physiological or N - (4 3 '- fluoro - bifenilmetil) - N - [2 - (3 - C Iano phenoxy ethyl) Amine or a Salt of the same Physiological acceptable for use.In the preparation of a Medicine for Veterinary medicine for the Treatment or prophylaxis of disorders associated with traumatic stressors self-directed behavior, compulsive Disorders associated with stressors and / or Behavioral Disorders anxiety Stressors associated with the behavior.Pharmaceutical preparation for use in Veterinary medicine for the treatment of disorders associated with Behavioral stressors that contains a combination of at least a dopamine D2 receptor antagonist and agonist of the 5-ht1a receptor.In particular, (R) - (-) - 2 - [5 - (4 - fluoro phenyl) - 3 - piridilmetilaminometil chromane] - or Salt acceptable to use the same Physiological or N - (4 '- fluoro - 3 - bifenilmetil) - N - [2 - (3 - cyano - phenoxy Ethyl amine Salt) or A physiologically acceptable for use in the same.